Prospective comparative study of long-term impact of radiofrequency ablation (RFA) versus stereotactic body radiotherapy (SBRT) on liver function in patients with single HCC
Not Applicable
- Conditions
- Hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000036081
- Lead Sponsor
- Department of Gastroenterology and Hepatology, Kurashiki Central Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
Child-Pugh score of 10 or more Palliative radiotherapy Informed consent not obtained
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes of ALBI score (comparison between baseline and 3 months after RFA/SBRT)
- Secondary Outcome Measures
Name Time Method ocal recurrence free survival Best treatment effect Recurrence Overall survival Changes of ALBI score (6, 9, and 12months) Changes of Child-Pugh score (3, 6, 9, and 12 months) Time to liver function worsening Adverse events